• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges 400 Points; Crude Oil Down 1%

    11/7/22 2:20:52 PM ET
    $ACMR
    $BTU
    $DINO
    $HUDI
    Industrial Machinery/Components
    Technology
    Coal Mining
    Energy
    Get the next $ACMR alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

    The Dow traded up 1.24% to 32,804.26 while the NASDAQ rose 0.67% to 10,545.27. The S&P 500 also rose, gaining, 0.78% to 3,799.81.

    Also check this: Volatility In Markets Decreases Following US Jobs Report


    Leading and Lagging Sectors


    Energy shares gained 1.5% on Monday. Leading the sector was strength from Millicom Peabody Energy Corporation (NYSE:BTU) and Uranium Royalty Corp. (NASDAQ:UROY).


    In trading on Monday, utilities shares tumbled by 3.1%.


    Top Headline

     

    HF Sinclair Corporation (NYSE:DINO) reported better-than-expected results for its third quarter on Monday.

    HF Sinclair posted quarterly earnings of $4.58 per share, topping market estimates of $4.12 per share. The company’s quarterly sales came in at $10.60 billion, versus expectations of $8.28 billion.


    Equities Trading UP

     

    • Veru Inc. (NASDAQ:VERU) shares shot up 35% to $14.00 following publication of briefing documents ahead of the Nov. 9 FDA Adcom meeting for its COVID-19 treatment candidate.
    • Shares of Oyster Point Pharma, Inc. (NASDAQ:OYST) got a boost, shooting 39% to $11.64 after the company announced it will be acquired by Viatris for $11 per share.
    • ACM Research, Inc. (NASDAQ:ACMR) shares were also up, gaining 26% to $8.35 after Jefferies upgraded the stock from Underperform to Hold. ACM Research, last week, reported better-than-expected Q3 results.

     

    Equities Trading DOWN

    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) shares tumbled 91% to $16.78 after the company reported pricing of $25 million registered direct offering.
    • Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) were down 26% to $23.02 after the company reported its VERVE-101 IND application was placed on hold by the FDA. The company also reported Q3 earnings results.
    • Inhibikase Therapeutics, Inc. (NASDAQ:IKT) was down, falling 40% to $0.4650 after the company announced an FDA clinical hold on its IkT-148009 programs.


    Also check out: Yelp, Twilio, Atlassian, And Other Big Losers From Friday


    Commodities

    In commodity news, oil traded down 1.1% to $91.64 while gold traded up 0.2% at $1,680.00.


    Silver traded up 0.7% to $20.93 on Monday while copper fell 2.2% to $3.6070.


    Euro zone


    European shares closed mostly higher today. The eurozone’s STOXX 600 gained 0.33%, London’s FTSE 100 fell 0.48% while Spain’s IBEX 35 Index rose 0.25%. The German DAX gained 0.55%, French CAC 40 rose 0.01% and Italy’s FTSE MIB Index jumped 0.90%.

    The S&P Global Eurozone construction PMI dropped to 44.9 in October versus 45.3 a month ago, signalling a contraction in output for the sixth striaght month. The S&P Global construction PMI for France dropped to 44.3 in October from 49.1 in the previous month, while German construction PMI came in at 43.8 for October. Industrial production in Germany increased 0.6% from a month ago in September

    The Halifax house price index in the UK climbed 8.3% year-over-year in October following a 9.8% growth in the previous month.


    Asia Pacific Markets


    Asian markets closed higher on Monday, with the Japan’s Nikkei climbing 1.21% and Hong Kong’s Hang Seng Index jumping 2.69%. China’s Shanghai Composite Index gained 0.23%.

    China's foreign exchange reserves increased to $3.052 trillion in October from $3.029 trillion in the earlier month. Chinese trade surplus widened to $85.2 billion in October from $84.8 billion in the year-ago month.


    Economics


    Data on consumer credit for September will be released at 3:00 p.m. ET.


    Check out this: Investor Sentiment Increases After Dow Jumps 400 Points


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 99,647,810 cases with around 1,098,230 deaths. India confirmed a total of at least 44,661,510 cases and 530,500 deaths, while France reported over 36,946,900 COVID-19 cases with 157,270 deaths. In total, there were at least 637,830,710 cases of COVID-19 worldwide with more than 6,605,910 deaths.

    Get the next $ACMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACMR
    $BTU
    $DINO
    $HUDI

    CompanyDatePrice TargetRatingAnalyst
    Inhibikase Therapeutics Inc.
    $IKT
    1/21/2026$6.00Buy
    BofA Securities
    HF Sinclair Corporation
    $DINO
    1/8/2026$68.00Neutral → Overweight
    Piper Sandler
    Inhibikase Therapeutics Inc.
    $IKT
    12/26/2025$8.00Buy
    H.C. Wainwright
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    Inhibikase Therapeutics Inc.
    $IKT
    12/11/2025$4.00Overweight
    Cantor Fitzgerald
    HF Sinclair Corporation
    $DINO
    10/17/2025$58.00Equal Weight
    Wells Fargo
    Uranium Royalty Corp.
    $UROY
    9/23/2025Outperform → Mkt Perform
    Raymond James
    HF Sinclair Corporation
    $DINO
    8/1/2025$45.00 → $46.00Hold
    TD Cowen
    More analyst ratings

    $ACMR
    $BTU
    $DINO
    $HUDI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Inhibikase Therapeutics with a new price target

    BofA Securities initiated coverage of Inhibikase Therapeutics with a rating of Buy and set a new price target of $6.00

    1/21/26 8:55:17 AM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    HF Sinclair upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded HF Sinclair from Neutral to Overweight and set a new price target of $68.00

    1/8/26 8:11:20 AM ET
    $DINO
    Natural Gas Distribution
    Energy

    H.C. Wainwright initiated coverage on Inhibikase Therapeutics with a new price target

    H.C. Wainwright initiated coverage of Inhibikase Therapeutics with a rating of Buy and set a new price target of $8.00

    12/26/25 8:50:26 AM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACMR
    $BTU
    $DINO
    $HUDI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Sands Capital Life Sciences Pulse Fund Ii, L.P. bought $2,999,999 worth of shares (2,068,965 units at $1.45) (SEC Form 4)

    4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)

    11/24/25 3:47:02 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Fernandez Manuel J bought $19,990 worth of shares (635 units at $31.48), increasing direct ownership by 5% to 14,235 units (SEC Form 4)

    4 - HF Sinclair Corp (0001915657) (Issuer)

    3/5/25 5:18:23 PM ET
    $DINO
    Natural Gas Distribution
    Energy

    Director Myers Franklin bought $178,314 worth of shares (5,000 units at $35.66), increasing direct ownership by 3% to 154,065 units (SEC Form 4)

    4 - HF Sinclair Corp (0001915657) (Issuer)

    2/26/25 5:03:18 PM ET
    $DINO
    Natural Gas Distribution
    Energy

    $ACMR
    $BTU
    $DINO
    $HUDI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Officer Wang David H

    4 - ACM Research, Inc. (0001680062) (Issuer)

    2/6/26 4:30:18 PM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    CAO and Corporate Secretary Jarboe Scott T. sold $73,693 worth of shares (2,151 units at $34.26), decreasing direct ownership by 3% to 82,306 units (SEC Form 4)

    4 - PEABODY ENERGY CORP (0001064728) (Issuer)

    1/16/26 4:06:52 PM ET
    $BTU
    Coal Mining
    Energy

    SEC Form 4 filed by Chief Executive Officer Iwicki Mark T

    4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)

    1/7/26 4:23:21 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACMR
    $BTU
    $DINO
    $HUDI
    SEC Filings

    View All

    ACM Research Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ACM Research, Inc. (0001680062) (Filer)

    2/6/26 8:17:57 AM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    Peabody Energy Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - PEABODY ENERGY CORP (0001064728) (Filer)

    2/5/26 7:47:26 AM ET
    $BTU
    Coal Mining
    Energy

    ACM Research Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ACM Research, Inc. (0001680062) (Filer)

    2/4/26 5:08:33 PM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    $ACMR
    $BTU
    $DINO
    $HUDI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ACM Research to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

    FREMONT, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. ("ACM") (NASDAQ:ACMR) announced today that it will release its financial results for the fourth quarter and fiscal year 2025 before the U.S. market open on Thursday, February 26, 2026. ACM will conduct a corresponding conference call at 8:00 a.m. U.S. Eastern Time (9:00 p.m. China Time) to discuss the results. What:ACM Fourth Quarter and Fiscal Year (ended December 31, 2025) Earnings CallWhen:8:00 a.m. U.S. Eastern Time on Thursday, February 26, 2026Webcast:ir.acmr.com/news-events/events   To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon

    2/9/26 4:05:00 PM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    Peabody Reports Results for the Quarter and Year Ended December 31, 2025

    Key Operational and Financial Metrics Meet or Exceed 2025 Full-Year Guidance Centurion Longwall Mining Ahead of Schedule U.S. Policy and Market Tailwinds Supportive of Increasing Coal Use ST. LOUIS, Feb. 5, 2026 /PRNewswire/ -- Peabody (NYSE:BTU) today reported fourth quarter net income attributable to common stockholders of $10.4 million, or $0.09 per diluted share, compared to $30.6 million, or $0.25 per diluted share, in the prior year quarter. Peabody had Adjusted EBITDA1 of $118.1 million in the fourth quarter of 2025, compared to $176.7 million in the fourth quarter of 2024. Full-year 2025 revenue totaled $3,861.5 million compared to $4,236.7 million in the prior year in the face of s

    2/5/26 7:46:00 AM ET
    $BTU
    Coal Mining
    Energy

    Peabody Board Declares Dividend on Common Stock

    ST. LOUIS, Feb. 5, 2026 /PRNewswire/ -- Peabody (NYSE:BTU) announced today that its Board of Directors has declared a quarterly dividend on its common stock of $0.075 per share, payable on March 10, 2026 to stockholders of record on February 23, 2026. Peabody is a leading coal producer, providing essential products for the production of affordable, reliable energy and steel. Our commitment to sustainability underpins everything we do and shapes our strategy for the future. For further information, visit PeabodyEnergy.com.  Contact:Vic Svec / Kala [email protected] Forward-Looking Statements This press release contains forward-looking statements within the meaning of the securities

    2/5/26 7:45:00 AM ET
    $BTU
    Coal Mining
    Energy

    $ACMR
    $BTU
    $DINO
    $HUDI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TYRVAYA issued to OYSTER POINT PHARMA INC

    Submission status for OYSTER POINT PHARMA INC's drug TYRVAYA (ORIG-1) with active ingredient VARENICLINE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 213978, Application Classification: Type 3 - New Dosage Form

    10/19/21 7:27:01 PM ET
    $OYST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $BTU
    $DINO
    $HUDI
    Leadership Updates

    Live Leadership Updates

    View All

    Uranium Royalty Announces Voting Results

    DESIGNATED NEWS RELEASE VANCOUVER, BC, Oct. 16, 2025 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ:UROY) (TSX:URC) ("URC" or the "Company") is pleased to announce that at its annual general meeting held on October 16, 2025 (the "Meeting" or "AGM"), all nominees listed in its management information circular dated September 9, 2025 were elected as directors of the Company. Each of the following six nominees proposed by management was elected as a director on a vote by show of hands.  The proxies received by management with respect to the election of directors were as follows: Director Total Votes For Total Votes Amir Adnani 35,606,472 46,208,738 Scott Melbye 36,419,052 46,208,738 Vina Patel 46

    10/16/25 6:35:00 PM ET
    $UROY
    Investment Bankers/Brokers/Service
    Finance

    ACM Research Set to Join S&P SmallCap 600

    NEW YORK, Sept. 22, 2025 /PRNewswire/ -- ACM Research Inc. (NASD: ACMR) will replace WK Kellogg Co. (NYSE:KLG) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, September 26. The Ferrero Group is acquiring WK Kellogg in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Sept 26, 2025 S&P SmallCap 600 Addition ACM Research ACMR Information Technology Sept 26, 2025 S&P SmallCap 600 Deletion WK Kellogg KLG Consumer Staples ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices i

    9/22/25 6:16:00 PM ET
    $ACMR
    $KLG
    $SPGI
    Industrial Machinery/Components
    Technology
    Packaged Foods
    Consumer Staples

    Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer

    BOSTON and ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics to modify the course of pulmonary arterial hypertension ("PAH"), today announced the appointment of veteran biopharma executive Timothy Pigot as the Company's Chief Commercial and Strategy Officer. "Tim Pigot is an accomplished pharma industry business leader and a deeply respected expert in the PAH market landscape, and we are delighted to welcome him to the Inhibikase team," said Mark Iwicki, Chief Executive Officer of Inhibikase. "As we advance IKT-001 toward a late-stage clinical trial in PAH, Tim'

    8/19/25 8:00:00 AM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACMR
    $BTU
    $DINO
    $HUDI
    Financials

    Live finance-specific insights

    View All

    ACM Research to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

    FREMONT, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. ("ACM") (NASDAQ:ACMR) announced today that it will release its financial results for the fourth quarter and fiscal year 2025 before the U.S. market open on Thursday, February 26, 2026. ACM will conduct a corresponding conference call at 8:00 a.m. U.S. Eastern Time (9:00 p.m. China Time) to discuss the results. What:ACM Fourth Quarter and Fiscal Year (ended December 31, 2025) Earnings CallWhen:8:00 a.m. U.S. Eastern Time on Thursday, February 26, 2026Webcast:ir.acmr.com/news-events/events   To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon

    2/9/26 4:05:00 PM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    Peabody Reports Results for the Quarter and Year Ended December 31, 2025

    Key Operational and Financial Metrics Meet or Exceed 2025 Full-Year Guidance Centurion Longwall Mining Ahead of Schedule U.S. Policy and Market Tailwinds Supportive of Increasing Coal Use ST. LOUIS, Feb. 5, 2026 /PRNewswire/ -- Peabody (NYSE:BTU) today reported fourth quarter net income attributable to common stockholders of $10.4 million, or $0.09 per diluted share, compared to $30.6 million, or $0.25 per diluted share, in the prior year quarter. Peabody had Adjusted EBITDA1 of $118.1 million in the fourth quarter of 2025, compared to $176.7 million in the fourth quarter of 2024. Full-year 2025 revenue totaled $3,861.5 million compared to $4,236.7 million in the prior year in the face of s

    2/5/26 7:46:00 AM ET
    $BTU
    Coal Mining
    Energy

    Peabody Board Declares Dividend on Common Stock

    ST. LOUIS, Feb. 5, 2026 /PRNewswire/ -- Peabody (NYSE:BTU) announced today that its Board of Directors has declared a quarterly dividend on its common stock of $0.075 per share, payable on March 10, 2026 to stockholders of record on February 23, 2026. Peabody is a leading coal producer, providing essential products for the production of affordable, reliable energy and steel. Our commitment to sustainability underpins everything we do and shapes our strategy for the future. For further information, visit PeabodyEnergy.com.  Contact:Vic Svec / Kala [email protected] Forward-Looking Statements This press release contains forward-looking statements within the meaning of the securities

    2/5/26 7:45:00 AM ET
    $BTU
    Coal Mining
    Energy

    $ACMR
    $BTU
    $DINO
    $HUDI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Verve Therapeutics Inc.

    SC 13G - Verve Therapeutics, Inc. (0001840574) (Subject)

    11/18/24 5:23:52 PM ET
    $VERV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Inhibikase Therapeutics Inc.

    SC 13G - Inhibikase Therapeutics, Inc. (0001750149) (Subject)

    11/14/24 3:31:08 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Uranium Royalty Corp.

    SC 13G - Uranium Royalty Corp. (0001711570) (Subject)

    11/14/24 2:24:59 PM ET
    $UROY
    Investment Bankers/Brokers/Service
    Finance